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ABSTRACT 
Objectives: To use genetic fingerprinting to investigate the epi- 
demiology of tuberculosis (TB) caused by Mycobacterium fuber- 
culosis in Poland, a country with a relatively high incidence of 
tuberculosis, to improve TB control. 
Design: One hundred M, tuberculosis isolates from 98 patients 
in the Institute of Tuberculosis and Lung Diseases in Warsaw 
from 1993 to 1995 and 85 isolates obtained from 50 patients 
in the Hospital of Lung Diseases in Lodz in 1996 were sub- 
jected to DNA restriction fragment length polymorphism (RFLP) 
analysis, using the insertion sequence IS61 IO as a probe. 
Results: IS61 lo-associated banding patterns of the M. tuber- 
culosis isolates originating from different localities varied con- 
siderably, but isolates from Lodz had a higher degree of 
similarity. Strains with identical RFLP types were identified in 
patients of the same family or patients living in the same area, 
indicating active transmission. Of strains isolated in Warsaw, 
45% were resistant to at least one drug, and 35% were resis- 
tant to two or more drugs and were classified as multidrug- 
resistant (MDR). Some drug-resistant isolates were found to 
have identical banding patterns and originated from epidemi- 
ologically linked cases. 
Conclusions: Active transmission of TB, including MDR TB, is 
occurring in Poland. Active measures must be taken to prevent 
the spread of drug-resistant TB in Poland and potentially, the 
rest of Europe. 
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In April 1993, the World Health Organization declared 
tuberculosis (TB) “a global health emergency.“l Tubercu- 
losis is back as an important threat to public health, 
owing to a complexity of factors, such as poverty, 
acquired immunodeficiency syndrome (AIDS), drug addic- 
tion, homelessness, and changes in public health policy. 
The emergence of multidrug resistant (MDR) strains of 
the causative agent Mycobacterium tuberculosis poses 
an additional threat of potentially returning TB control to 
the ineffective treatments of the pre-antibiotic era. 
The analysis of tuberculous transmission and the 
tracing of the sources of infection require the ability to 
discriminate among M. tuberculosis strains. Several 
methods have been used for typing these strains. Until 
recently, all the methods relied on the study of pheno- 
typic traits, such as serotype, biotype, bacteriophage sen- 
sitivity, or sensitivity to antimicrobial agents. These 
techniques have intrinsic limitations. For example, phe- 
notypic expression may vary with culture conditions, 
and there is only a small number of phage types. To over- 
come these difficulties, genetic markers for the identifi- 
cation of strains within the M. tuberculosis complex 
have been described. Of the five repetitive elements that 
so far have been discovered in M. tuberculosis complex 
strains, the insertion element IS6110 has proved to be 
the most useful marker for epidemiologic studies.z-4 
Restriction fragment length polymorphism (RFLP) analy- 
sis based on IS61 IO has been useful for identifying trans- 
mission during outbreaks, 5-7 for distinguishing between 
new infection and reactivation in patients who relapsed 
after treatment,s and for the demonstration of cross-con- 
tamination of cultures in laboratories9 Furthermore, an 
internationally accepted consensus for the standardized 
use of IS61 10 DNA fingerprinting of M. tuberculosis 
strains has been established.‘O 
In this study, M. tuberculosis isolates from Polish TB 
patients between 1993 and 1996, were typed by the RFLP 
method, using a probe for IS6110, and drug-resistance 
profiles also were obtained. Evidence was found of active 
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transmission of TB in Poland, including TB caused by 
MDR strains of M. tuberculosis. 
MATERIAL AND METHODS 
Bacterial Isolates and Clinical Data 
One hundred isolates of M. tuberculosis analyzed in this 
study were collected at the Department of Microbiology 
at the Institute of Tuberculosis and Lung Diseases in War- 
saw, Poland. This laboratory serves as a diagnostic ser- 
vice laboratory for Central Poland and as a reference 
laboratory for all of the country. The isolates were ran- 
domly sampled from late 1993 to the end of 1995. The 
remaining 85 isolates were obtained in 1996 in the Hos- 
pital of Lung Diseases in Lodz. Data on the patients con- 
cerning type of specimen, date of isolatio.n, clinical 
diagnosis, TB status (pulmonary versus extrapulmonary), 
human immunodeficiency virus (HIV) status, chemother- 
apeutic regimens, and standard demographic data were 
registered. 
The 185 isolates were isolated from sputum (165 
specimens), bronchoalveolar fluid (n = 4), bronchoalve- 
olar lavage (n = 2), bronchial aspirate (n = 3), pleural 
fluid (n = 2), pleural lavage (n = l), stomach lavage 
(n = 4), urine (n = 2), throat swab (n = l), and wound 
swab (n = 1). However, in some cases in whiclh multiple 
isolates were from the same patient, each of the strains 
was identical by RJYLP typing to the first isolate. There- 
fore, only 148 isolates were included (one for each 
patient) in this study. 
The species identification of the isolates Ywas based 
on standard microbiologic tests. All the isolates were 
examined for their susceptibility to isoniazid, strepto- 
mycin, ethambutol, and rifampin. The susceptibilities of 
the 100 isolates from Warsaw to para-aminosalicylic acid 
(PAS), ofloxacin, cycloserine, ethionamide, and capre- 
omycin also were determined, as described previously.ll 
DNA Fingerprinting 
Total genomic DNA from each M. tuberculosis isolate 
was prepared essentially as described elsewhere,12 and 
digested with PvuII for ISGIIO-RFLP and IS18081-RFLP, 
and with AZuI for direct repeat (DR)-RFLP Southern 
blot experiments were performed as described previ- 
ously.* Three DNA probes were used: (1) IS6110 probe, 
a 245-bp, polymerase chain reaction (PCR)-amplified 
DNA fragment generated from the 5’ end of IS61Z012; 
(2) IS3081 probe, a 236-bp product amplified by PCR12; 
and (3) a DR-r probe, a 36-bp oligonucleotide flanking 
the IS6110 element.13 The DNA probes were nonradio- 
actively labelled with a DIG DNA labelling kit 
(Boehringer Mannheim, Mannheim, Germany). The 
PvuII-digested chromosomal DNA of M. tuberculosis 
Mt14323 was used as a reference in each analysis.” 
Analyses of Restriction Fragment 
Length Polymorphism Patterns 
The DNA fingerprint patterns of the isolates were com- 
pared both by computer-assisted analyses, using the Win- 
dows versions of Gelcompar (version 3.lb, Applied 
Maths, Kortrijk, Belgium) and ScanPack (version 3.0, Bio- 
metra, Germany), as well as by visual examination. Com- 
parisons of patterns were done by the unweighted pair 
group method, using arithmetic averages (unweighted- 
pair group analysis [UPGMA] clustering method), by using 
the Dice coefficient according to the instructions of the 
manufacturers (Applied Maths). The clustering generated 
was consistent with visual inspection of the data. In the 
few cases where multiple isolates were obtained from 
the same patient, they each were found to give identical 
RFLP patterns. 
RESULTS 
Patient Characteristics 
One hundred eighty-five isolates from 148 patients were 
analyzed. Of these, 98 patients represent 24% of the TB 
patients examined with bacteriologic confirmation and 
1% of all examined patients (positive and negative cul- 
tures) in the Institute of Tuberculosis and Lung Diseases 
in Warsaw between 1993 and 1995. The remaining 50 
patients represent 21% of the patients notified with bac- 
teriologic confirmation of TB and 11% of all investigated 
patients in the Hospital of Lung Diseases in Lodz in 1996 
(Table 1). 
Most of the patients were of Polish origin (98.6%); 
only two patients (1.4%) were immigrants from foreign 
countries: one from Ukraine and one from Armenia. The 
patient ages were between 17 and 90 years; about 71% 
of the patients were between 20 and 60 years of age. 
Most of the patients (71.4%) were men. None were HIV 
positive. 
Table 1. Numbers of Patients with TB Notified in Poland in 
1993-I 996 and Enrolled in this Study 
Number of Bacteriologic RFLP Analysis 
Patients Confirmation of M. tuberculosis 
Year Investigated of TB Strains 
Institute of Tuberculosis and Lung Diseases, Warsaw 
1993 3079 123 7 
1994 2919 126 30 
1995 2887 158 61 
Total 8885 407 98 
Hospital of Lung Diseases, Lodz 
1996 460 242 50 
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Table 2. Drug Resistance Profiles of M. tuberculosis Strains from the Institute of Tuberculosis and Lung Diseases in Warsaw* 
Number of Resistant Strains Isolated 
Group+ Drug 7994 (%) 1995 (%) Total (‘96) 
I SM 0 4 (6.6) 4 (4.4) 
INH 0 4 (6.6) 4 (4.4) 
RMP 0 1 (1.6) 1 (1.1) 
II INH, RMP 1 (3.3) 2 (3.3) 3 (3.3) 
SM, RMP 1 (3.3) 1 (1.6) 2 (2.2) 
SM, ETA 0 1 (1 .6) 1 (1.1) 
Ill PAS, SM, INH 1 (3.3) 1 (1.6) 2 (2.2) 
PAS, SM, OFL 0 1 (1.6) 1 (1.1) 
RMP, SM, INH 0 7 (11.5) 7 (7.7) 
ETA, SM, INH 0 1 (1.6) 1 (1.1) 
RMP, EMB, INH 0 2 (3.3) 2 (2.2) 
IV Resistant to more than 3 drugs 1 (3.3) 12 (19.7) 13 (14.3) 
Total 4/30 (13.3) 37/61 (60.7) 41191 (45.1) 
*A total of 91 strains were tested (30 from 1994 and 61 from 1995). Drug resistance patterns of seven strains from 1993 were not available. +Groups I, II, III, and IV 
include strains resistant to 1, 2, 3, or more than 3 drugs, respectively. SM = streptomycin; INH = isoniazid; ETA = ethionamide; RMP = rifampin; EMB = ethambutol; 
PAS = para-aminosalicylic acid; OFL = ofloxacin. 
Strain Characteristics 1~6110 Copy Numbers 
Drug Resistance Patterns 
The drug resistance patterns of 91 isolates obtained in the 
Institute of Tuberculosis in Warsaw are given in Table 2. 
Forty-one (45.1%) isolates were found to be resistant to 
at least one antituberculous drug, and 32 isolates (35.2%) 
were resistant to two or more drugs. There was a large 
increase in the number of resistant isolates identified in 
1995 (60.7%) compared to 1994 (13.3%) and most of 
these (75%) were MDR strains. Among 50 isolates iso- 
lated in 1996 in the Hospital of Lung Diseases in Lodz 
only one isolate (2%) was observed to be resistant to 
isoniazid. 
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Figure 1. DNA fingerprints of 16 M. tuberculosis strains originating 
from Poland. Southern blots of Pvull-digested chromosomal DNA 
hybridized with 245bp PCR fragments of IS61 IO. Numbers on the 
left indicate the sizes of standard DNA fragments (in kilobase pairs). 
Lane 18 represents DNA of M. tuberculosis reference strain Mt14323. 
The copy number of IS6110 in each of the isolates was 
determined from the number of bands hybridizing to the 
probe, and ranged from 0 to 18. Figure 1 shows IS6110 
RFLP patterns of 16 clinical isolates of M. tuberculosis. 
The DNA extracted from two isolates obtained from Pol- 
ish patients did not hybridize with IS61 10 DNA. Also, by 
PCR with the INS1 and INS2 primers5 no amplifiable 
IS6110 DNA was found in these strains. Hybridization 
patterns consistent with M. tuberculosis with the IS1081 
and DR-r probes were demonstrated for both of these 
strains. The majority, 126 of the 148 investigated isolates 
(85%) contained between 6 and 11 copies of ISGZIO. 
None of the strains carried only a single copy of the 
element. 
DNA Polymorphism 
As shown in Table 3, 91 different DNA fingerprint pat- 
terns were observed in the 96 isolates from Warsaw (the 
two isolates carrying no IS6110 element were excluded). 
Of the 91 patterns, only four were shared by two or three 
isolates, whereas the remaining 87 isolates (90.6% of iso- 
lates) gave unique fingerprint patterns. The relatively low 
Table 3. Polymorphisms of M. tuberculosis Isolates from 
146 Patients with Tuberculosis in Poland (1993-1996)* 
Unique Number of Number 
Year Strains Clusters in Clusters 
Institute of Tuberculosis and Lung Diseases, Warsaw 
1993 5 1 2 
1994 27 1 2 
1995 55 2 2-3 
Total 87 4 5-6 
Hospital of Lung Diseases, Lodz 
1996 28 9-10 2-4 
*Excluding two isolates carrying no IS61 IO element. 
Total 
7 
29 
60 
96 
50 
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level of clustering (9.4%) likely reflects the wide geo- 
graphic area from which these strains were derived. In 
contrast, among the 50 strains isolated in Lodz in 1996, 
only 38 different DNA fingerprint patterns we:re revealed 
(see Table 3). Of these 38 RFLP types, nine were shared 
by two strains and one was identical for four strains. The 
remaining 28 patterns (56% of strains) were unique. The 
level of clustering of 44% was high compared to that of 
the Warsaw strains, indicating that active transmission is 
occurring in defmed localities within Poland, such as the 
city of Lodz. To further investigate those strains’ with iden- 
tical RFLP patterns, place of residence of patients was 
examined. Of the four clusters of strains with identical 
RFLP patterns in the Warsaw strain collection, two clus- 
ters were found to have originated from single localities. 
The most prevalent pattern involved three strains iso- 
lated in 1995 from patients originating from a single town 
in Silesia (southern Poland). Two of the three isolates 
were obtained from members of the same family (one 
patient and his wife), indicating that active transmission 
of the infection resulted from family contact. These two 
isolates were also identical in the analysis of the poly- 
morphism in the region containing the DR elements, 
whereas the third member of this cluster exhibited a dif- 
ferent DR RFLP pattern. This observation is in agreement 
with previously published data showing that M. tuber- 
culosis strains that share the same IS6210 RFLP type can 
differ in their DR RFLP patterns.13 Of the three pairs of 
strains with identical IS6110 RFLP types, one (isolated in 
1993) was identified in two patients originating from a 
single town in Mazovia (eastern Poland). These strains 
were also identical by DR fingerprinting. The other two 
pairs of identical strains were from patients with no 
apparent epidemiologic links. A higher numbler of clus- 
tered strains (22 versus 9) were found among the iso- 
lates obtained in a local hospital in Lodz. In a few cases 
the strains with identical DNA fingerprint patterns were 
isolated from patients living in the same district of the 
town, indicating active transmission of the disease. None 
of the patients belonging to these chains of transmission 
were of foreign origin, and there was no significant age 
difference between patients with unique strains and those 
with clustered strains. 
Investigation of Correlation between ResB-iction 
Fragment Length Polymorphism Types and Drug 
Resistance 
IS6110 DNA fmgerprints of 42 drug-resistant isolates were 
compared with those of 99 drug-sensitive isolates. The 
results showed no noticeable difference in banding pat- 
tern or copy number of 1~6110 between drug-sensitive 
and drug-resistant isolates. Susceptible and resistant or 
even MDR strains were found in the same clusters. One 
clone of three MDR isolates was also identified. Two of 
the isolates exhibited identical drug resistance profiles 
and came from the epidemiologically linked TB cases 
from Silesia. The third isolate of this clone was isolated 
from a patient without apparent epidemiologic relations 
with the two other patients, was resistant to two extra 
drugs (ethambutol and capreomycin), and showed a 
different DR-RFLP pattern. 
DISCUSSION 
Poland is a central European country with 38.6 million 
inhabitants (1997). The social security system is mainly 
public and is financed through taxes. A monitoring and 
prevention policy for TB was implemented in 1957. The 
general standard of living has improved during the post- 
war decades, up until the 1980s when a significant dete- 
rioration of socioeconomic conditions was observed due 
to substantial political and economic changes. The patient 
notification rate was 39.8 per 100,000 in 1996.‘* For com- 
parison, the incidence of TB in different regions in France 
ranged between 9 and 36 per 100,000 in 1991,15 and was 
as low as 5.4 per 100,000 in Denmark in 1992.‘” 
IS6110 DNA fingerprinting demonstrated that the 
degree of DNA polymorphism of Polish M. tuberculosis 
strains examined in this study was high. The average num- 
ber of isolates per pattern was 1.05 for the strains from 
Warsaw, whereas for the recent study in NewYork it was 
1.35,17 and for the study in San Francisco, it was 1.5.18 It 
might be expected that regions suffering from a high 
level of TB transmission and insufficient hospital facilities, 
with a high risk of nosocomial infections, would be char- 
acterized by a relatively limited variety of mycobacterial 
clones. The diversity of patterns observed in the present 
study may be explained by the fact that the majority of 
analyzed strains were isolated from TB patients originat- 
ing from different regions of the country. On the other 
hand, the 50 strains isolated in the Hospital of Lung Dis- 
eases in Lodz showed a relatively high level of clustering 
(44%) and a corresponding low level of DNA polymor- 
phism (number of isolates per pattern was 1.32). The lev- 
els of clustering are similar to those described recently 
in New York and San Francisco.“zls Lodz is the second 
biggest city in Poland, with about 839,000 inhabitants (in 
1997). It is an important industrial, trade, and communi- 
cation center. Despite the mobility of the local population 
during the last few decades, the authors found a signifi- 
cant level of clustering of strains, indicating active trans- 
mission of TB in this area. The results indicate that, in 
contrast to most western European countries, active tmns- 
mission among HIV-negative patients is a significant fac- 
tor in the epidemiology of TB in Poland and indicates 
the need for better control measures to prevent spread 
of infection. 
In accordance with recent observations from a large- 
scale RFLP study of M. tuberculosis isolates in Tunisia,1o 
French Polynesia,‘* and Denmark,16 the majority of iso- 
lates investigated in the present study (85%) carried from 
6 to 11 copies of the IS6110 element. Two isolates were 
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found not to carry any detectable IS6110 element. 
Hybridization experiments with other genetic markers 
revealed the presence of DR and IS1081 DNAs in the 
genomes of these strains. This observation is unique for 
European populations, as to date such cases have been 
reported only for M. tuberculosis strains isolated from 
patients originating from Asia, mainly from India and Viet- 
nam.3s19 The absence of IS6110 in Polish isolates of M. 
tuberculosis indicates that diagnosis of TB based on PCR- 
amplification of IS6110 may lead to false-negative results 
for some European isolates.5 
Resistance to anti-TB drugs can develop as a result of 
treatment (secondary resistance), but it also can occur 
as a result of infection with drug-resistant strains of M. 
tuberculosis (primary resistance). In the present study, 
drug resistance to one or more anti-TB drugs was found 
in 45% of the isolates obtained in the Institute of Tuber- 
culosis and Lung Diseases in Warsaw. The MDR isolates 
(resistant to two or more drugs) accounted for 35.2% of 
the total number of those isolates but 75% of isolates 
from 1995. The majority of the isolates analyzed in the 
present study were isolated in the Institute of Tubercu- 
losis and Lung Diseases in Warsaw where selected TB 
cases are treated (e.g., those difficult to diagnose, uncared- 
for in treatment, or patients with chronic tuberculous 
disease).” Thus, the results are not representative for the 
whole Polish population. According to the first large-scale 
study of drug-resistant TB in Poland, 6.9% of M. tubercu- 
losis isolates were resistant (Professor Zofia Zwolska, 
World Health Organization/International Union against 
Tuberculosis and Lung Disease [IUATLD] global project 
on anti-tuberculosis drug resistance surveillance. Poland 
1996- 1997. Unpublished results). Monoresistance to iso- 
niazid and streptomycin was predominant (2.4% and 
1.6%, respectively). The isolates resistant to two drugs 
accounted for 1.3% (resistance to streptomycin and iso- 
niazid was predominant in this group and accounted for 
0.8%) whereas 1.5% of all the tested isolates were resis- 
tant to three anti-TB drugs. In this latter group resistance 
to streptomycin, isoniazid, and rifampin was predominant 
(1.2%) and 0.4% of the isolates were resistant to all four 
drugs tested (streptomycin, isoniazid, rifampin, and etham- 
butol). The increasing frequency of MDR strains from 
1994 to I995 in the present study may reflect regional 
differences in the rate of MDR TB in Poland but, never- 
theless, is cause for concern, and indicates that the situ- 
ation should be carefully monitored. 
In accordance with previous findings,15sz0 no gross 
differences in RFLP patterns were observed between 
drug-sensitive and drug-resistant isolates. However, a few 
clones of drug-resistant strains were found to infect small 
groups of epidemiologically linked patients. This indi- 
cates that active transmission of drug-resistant M. tuber- 
culosis strains is taking place in Poland. This observation 
is of considerable importance in terms of geographic 
localization of Poland in the center of Europe, and increas- 
ing migration across country borders that facilitates the 
transfer of infectious, airborne diseases like tuberculosis. 
In conclusion, the typing of isolates isolated from TB 
patients in Poland over 3 years provided insight into the 
status of tuberculosis in this region. The results indicate 
that active transmission of M. tuberculosis, including drug- 
resistant strains, is taking place in Poland and that urgent 
control measures may be necessary to prevent the spread 
of drug-resistant TB within Poland and, potentially, the 
rest of Europe. 
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